The global estradiol transdermal patches market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Estradiol is a form of estrogen which is a female sex hormone produced by the ovaries necessary for many processes in the body. Additionally, estradiol transdermal patches are used for the treatment of certain symptoms of menopause such as hot flashes, vaginal dryness, burning, and irritation. The major factor driving the demand for estradiol transdermal patches is the new product launches and drug approval across the globe. 

For instance, in December 2020, Agile Therapeutics, Inc. announced the launch of the Twirla (levonorgestrel and Ethinyl estradiol) transdermal system in the US. It is a non-daily, non-invasive contraceptive patch available by prescription for women of reproductive potential with a body mass index (BMI) <30 kg/m2 for whom a combined hormonal contraceptive is appropriate to prevent pregnancy. Furthermore, the market is also growing due to the increasing application of these patches in males and females for treatment.

Some major players in the market include Novartis International AG, Bayer AG, and Johnson & Johnson Services, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, Amneal Pharmaceuticals, Inc. announced the approval of Abbreviated New Drug Application (ANDA) for 150 mcg/day Norelgestromin and 35 mcg/day Ethinyl Estradiol Transdermal System from the US Food and Drug Administration (FDA). Additionally, the company also received a Competitive Generic Therapy (CGT) designation with 180 days of exclusivity.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Novartis International AG, Bayer AG, and Johnson & Johnson Services, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How players are addressing challenges to sustain growth?

• Where is the investment opportunity?

Global Estradiol Transdermal Patches Market Report by Segment

By Type

• 25 mg/day

• 50 mg/day

• 75 mg/day

• 100 mg/day

By Application 

• Male 

• Female

Global Estradiol Transdermal Patches Market Report by Region

North America

• United States

• Canada

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa